TrialClinical and vaccine immunology : CVI2009

Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults.

Clayton Harro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.